FI860711A0 - Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. - Google Patents

Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.

Info

Publication number
FI860711A0
FI860711A0 FI860711A FI860711A FI860711A0 FI 860711 A0 FI860711 A0 FI 860711A0 FI 860711 A FI860711 A FI 860711A FI 860711 A FI860711 A FI 860711A FI 860711 A0 FI860711 A0 FI 860711A0
Authority
FI
Finland
Prior art keywords
dessa
innehaolllande
dikarboxylsyror
alfa
omega
Prior art date
Application number
FI860711A
Other languages
English (en)
Finnish (fi)
Other versions
FI860711A7 (fi
Inventor
Jacob Bar-Tana
Ernst-Christian Witte
Bernd Hagenbruch
Johannes Pill
Karlheinz Stegmeier
Original Assignee
Epis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epis Sa filed Critical Epis Sa
Publication of FI860711A7 publication Critical patent/FI860711A7/fi
Publication of FI860711A0 publication Critical patent/FI860711A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/26—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings
    • C07C55/28—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/32—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/34—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI860711A 1984-06-22 1986-02-17 Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. FI860711A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843423166 DE3423166A1 (de) 1984-06-22 1984-06-22 Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
PCT/EP1985/000288 WO1986000298A1 (fr) 1984-06-22 1985-06-15 Acides alpha, omega dicarboxyliques, procede pour leur preparation et medicaments les renfermant

Publications (2)

Publication Number Publication Date
FI860711A7 FI860711A7 (fi) 1986-02-17
FI860711A0 true FI860711A0 (fi) 1986-02-17

Family

ID=6238954

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860711A FI860711A0 (fi) 1984-06-22 1986-02-17 Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.

Country Status (17)

Country Link
US (1) US4711896A (enExample)
EP (1) EP0185080B1 (enExample)
JP (1) JPH0780807B2 (enExample)
AU (1) AU4607185A (enExample)
CA (1) CA1262552A (enExample)
DD (1) DD240541A5 (enExample)
DE (2) DE3423166A1 (enExample)
DK (1) DK75986A (enExample)
ES (1) ES8604090A1 (enExample)
FI (1) FI860711A0 (enExample)
GR (1) GR851509B (enExample)
HU (1) HUT38892A (enExample)
IL (1) IL75549A (enExample)
NO (1) NO860661L (enExample)
PT (1) PT80681B (enExample)
WO (1) WO1986000298A1 (enExample)
ZA (1) ZA854684B (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US5602164A (en) * 1992-04-28 1997-02-11 Senyorina Ltd. Anti-obesity drugs
IL101708A (en) * 1992-04-28 1996-08-04 Senyorina Ltd Anti-fattening drugs comprising amino acid derivatives
TW322493B (enExample) * 1994-06-27 1997-12-11 Shell Int Research
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
IL119971A (en) 1997-01-07 2003-02-12 Yissum Res Dev Co Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
US20020037876A1 (en) * 1998-06-25 2002-03-28 Yissum Research Development Company Of Hebrew University Of Jerusalem Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
IL121165A0 (en) 1997-06-26 1997-11-20 Yissum Res Dev Co Pharmaceutical compositions containing carboxylic acids and derivatives thereof
US6459003B1 (en) 1999-04-01 2002-10-01 Esperion Therapeutics, Inc. Ether compounds
CN1962596A (zh) 2000-10-11 2007-05-16 埃斯佩里安医疗公司 用于控制胆固醇以及相关用途的酮化合物以及组合物
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
MXPA03003021A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de eter y composiciones para el control del colesterol y usos relacionados.
JP2004531459A (ja) 2000-10-11 2004-10-14 エスペリオン セラピューティクス,インコーポレイテッド コレステロールマネージメント用スルホキシドおよびビススルホキシド化合物ならびに組成物および関連する使用
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
WO2002030884A2 (en) 2000-10-11 2002-04-18 Esperion Therapeutics, Inc. Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
CA2480415A1 (en) * 2002-04-10 2003-10-23 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
JP2006509722A (ja) * 2002-07-03 2006-03-23 エスペリオン セラピューティクス,インコーポレイテッド 脂質代謝異常を治療するためのパンテチン含有組成物
US20040048910A1 (en) * 2002-08-22 2004-03-11 Bove Susan Elizabeth Method of treating osteoarthritis
US7335689B2 (en) 2003-01-23 2008-02-26 Esperion Therapeutics, Inc. Dihydroxyl compounds and compositions for cholesterol management and related uses
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
US7390504B2 (en) * 2003-11-07 2008-06-24 Jj Pharma, Inc. HDL-boosting combination therapy complexes
US20050192347A1 (en) * 2003-12-23 2005-09-01 Dasseux Jean-Louis H. Urea and thiourea compounds and compositions for cholesterol management and related uses
US7705177B2 (en) 2003-12-24 2010-04-27 Esperion Therapuetics, Inc. Ketone compounds and compositions for cholesterol management and related uses
US20090018199A1 (en) * 2003-12-30 2009-01-15 Syndrome X Ltd. Methods of Administering 3, 3, 14, 14 Tetramethyl Hexadecane 1, 16 Dioic Acid
KR20070043711A (ko) * 2004-06-09 2007-04-25 아바니르 파마슈티컬스 고콜레스테롤혈증과 관련 질환의 치료를 위한 소분자
MXJL06000069A (es) * 2004-06-09 2007-04-10 Avanir Pharmaceuticals Derivados heterociclicos para el tratamiento de hiperlipidemia y enfermedades relacionadas.
EP1753782A1 (en) * 2004-06-09 2007-02-21 Avanir Pharmaceuticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
US7846915B2 (en) * 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2007016525A2 (en) * 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
IL181577A0 (en) * 2007-02-26 2007-07-04 Jacob Bar Tana Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
EP2431043A1 (en) 2007-05-23 2012-03-21 Amcol International Corporation Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
NZ617779A (en) 2009-03-18 2015-08-28 Resverlogix Corp Novel anti-inflammatory agents
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
KR101660578B1 (ko) 2009-09-03 2016-09-27 화이자 백신스 엘엘씨 Pcsk9 백신
JP2013537240A (ja) 2010-09-20 2013-09-30 カリウス セラピューティクス エスエー 糖尿病および脂質異常症の処置のための方法および組成物
WO2012131504A1 (en) 2011-03-02 2012-10-04 Pfizer Inc. Pcsk9 vaccine
PT2773354T (pt) 2011-11-01 2019-07-17 Resverlogix Corp Formulações orais de libertação imediata para quinazolinonas substituídas
EP2787986B1 (en) 2011-12-08 2017-10-18 Syndromex Ltd. Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. ブロモドメイン阻害剤としての新規複素環式化合物
EP3104877B1 (en) 2014-02-11 2020-01-22 The USA, as represented by The Secretary, Department of Health and Human Services Pcsk9 vaccine and methods of using the same
CN114984016A (zh) 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
MX392182B (es) 2015-03-13 2025-03-21 Esperion Therapeutics Inc Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular.
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
CN107118098B (zh) * 2016-02-25 2020-07-14 中国科学院上海药物研究所 一类脂肪酸类化合物、其制备方法及其用途
US10512624B2 (en) 2016-11-30 2019-12-24 Syndromex Ltd. Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1
CN112437765A (zh) 2019-06-21 2021-03-02 艾斯柏伦治疗公司 贝派地酸的盐形式及其使用方法
EP4003314B1 (en) 2019-07-26 2024-07-10 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease
AU2022209835B2 (en) * 2021-01-25 2026-05-21 Espervita Therapeutics, Inc. Functionalized long-chain carboxylic acids, and their use for treatment of disease
WO2022159811A1 (en) 2021-01-25 2022-07-28 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
CN115894220A (zh) * 2021-09-23 2023-04-04 中国科学院上海药物研究所 一类作用于acly的长链类化合物、其制备方法及其用途
CN115887435A (zh) * 2021-09-23 2023-04-04 博骥源(上海)生物医药有限公司 长链类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210786B (de) * 1962-12-17 1966-02-17 Shell Int Research Verfahren zur Herstellung von p-Phenylen-bis (3, 3'-isovaleriansaeure) und 3-Phenylisovalerian-saeure
GB1556660A (en) * 1975-10-07 1979-11-28 Akzo Nv Di-carboxylic acid derivatives
IL64542A0 (en) * 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI860711A7 (fi) 1986-02-17
DD240541A5 (de) 1986-11-05
EP0185080A1 (enExample) 1986-06-25
PT80681B (de) 1987-05-08
JPS61502537A (ja) 1986-11-06
ES8604090A1 (es) 1986-02-01
DE3423166A1 (de) 1986-01-02
IL75549A (en) 1989-03-31
DE3574130D1 (en) 1989-12-14
GR851509B (enExample) 1985-06-25
CA1262552A (en) 1989-10-31
DK75986D0 (da) 1986-02-18
AU4607185A (en) 1986-01-24
IL75549A0 (en) 1985-10-31
ES544439A0 (es) 1986-02-01
PT80681A (de) 1985-07-01
HUT38892A (en) 1986-07-28
ZA854684B (en) 1986-02-26
DK75986A (da) 1986-02-18
JPH0780807B2 (ja) 1995-08-30
EP0185080B1 (de) 1989-11-08
NO860661L (no) 1986-02-21
US4711896A (en) 1987-12-08
WO1986000298A1 (fr) 1986-01-16

Similar Documents

Publication Publication Date Title
FI863200A7 (fi) Kolfibriller, foerfarande foer framstaellning av desamma samt kompositioner innehaollande desamma.
FI860711A7 (fi) Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.
FI851869A0 (fi) Nya pyrrolo-bensimidazoler, foerfarande foer framstaellning av desamma och laekemedel innehaollande dessa foereningar samt mellanprodukter.
FI842110L (fi) Foerfarande foer styrning av saogblad, samt anordning foer utfoerande av foerfarandet.
FI852203L (fi) 7-amino-1-cyklopropyl-6, 8-dihalogen-1, 4-dihydro-4-oxo-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning samt dessa innehaollande antibakteriella aemnen.
FI851533A0 (fi) Foerfarande foer aostadkomma undertryck i en sektor av en vals, samt en sugvals.
FI853611L (fi) Bloedningshaemmande proteiner, foerfarande foer framstaellning samt deras anvaendning.
FI855053L (fi) Foerfarande foer aostadkommande av en roerelsesignal samt mri-tomografianlaeggning foer utfoerande av naemnda foerfarande.
FI862893A0 (fi) Foerfarande foer mottagning av radiosaenda meddelanden samt mottagare foer aendamaolet.
FI863130A7 (fi) Anropssystem av armbandsurtyp samt till detta anknutet saendningsfoerfarande.
FI851736L (fi) Amidinohydrazoner av tetralin-, kromon-, tiokromon- och tetrahydrokinolinderivat, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI884424A0 (fi) Alkadienderivat, deras framstaellningsfoerfaranden, dessa innehaollande laekemedel samt mellanprodukter.
FI880164L (fi) Staolband samt av staolbandet framstaellt verktyg.
FI861257A7 (fi) Antistatiska hoegre n-alkyl- och n-alkenylneoalkanoamider, foerfarande foer framstaellning av dessa, antistatiska kompositioner innehaollande saodana amider samt foerfarande foer minskning av ackumulering av statiska laddningar i tvaett.
FI843959A0 (fi) Nytt foerfarande foer framstaellning av kefalosporiner, vid framstaellning av kefalosporin anvaendbar mellanprodukt samt foerfarande foer framstaellning av naemnda mellanprodukt.
FI860426L (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
FI863837L (fi) Foerfarande foer foerpackning av livsmedel, saerskilt matportioner samt medelst foerfarandet aostadkommen foerpackning.
FI882177A0 (fi) Diarylalkylsubstituerade alkylaminer, deras framstaellningsfoerfarande, deras anvaendning samt dessa innehaollande laekemedel.
FI855085A7 (fi) En blandning av olika dihydropyridiner, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI861073A0 (fi) Foerfarande foer framstaellning av guanidiner, saosom linoglirid, samt foerfarande foer framstaellning av mellanprodukter.
FI842338A0 (fi) 2-azabicyklo/2.2.2./oktanderivat, foerfarande foer framstaellning av dessa samt dessa innehaollande farmaceutiska aemnen.
FI852914A0 (fi) Fjaederkraftackumulator foer en av lasten beroende samt fjaerrstyrd frigoering av en dornfoersedd lastmottagande anordning.
FI853882L (fi) Foerfarande foer framstaellning av cellulosafiber respektive aendloesa cellulosafiber samt anordning foer utfoerande av foerfarandet.
FI852934A0 (fi) Foerfarande foer montering av lagerlamellen i kamrullen i en hydraulmotors kolv, lageranordning foer kamrulle samt en lagerlamell.
FI840835A7 (fi) Foerfarande foer tillverkning av en ihaolig traestaong, anordning foer tillaempning av foerfarandet samt en med foerfarandet aostadkommen ihaolig traestaong.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: EPIS S.A.